INS and Hyperglycemia: In fact, NGR1 augmented both phases of glucose-stimulated insulin secretion indicating that NGR1 also acts by potentiating glucose-induced insulin secretion to reduce postprandial hyperglycemia similar to GLP-1 agonists, well-known antidiabetic class of drugs.